Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upneeq for eyelid position and redness
NCT04831047Phase 4Completed
- Sponsor
- University of Miami
- Start
- Jun 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oxymetazoline in blepharoptosis, Conjunctival hyperemia, sponsored by University of Miami. Started Jun 2021; status: completed.
02
Drugs
oxymetazoline
03
Conditions
blepharoptosisConjunctival hyperemia
Beyond the preview
Go deeper on NCT04831047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04831047.